Live Breaking News & Updates on Lorenza Rimassa

Stay updated with breaking news from Lorenza rimassa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ipsen : announces clinical data to be presented at ASCO demonstrating its commitment to patients with cancer -Today at 09:52 am

Paris , 29 May 2018 - Ipsen today announced that
cabozantinib and irinotecan liposome injection are the subject of 8
presentations at the 2018 American Society of Clinical. ....

United States , Cabozantinib Cabometyx , Robin Kelley , Ipsen Euronext , Lorenza Rimassa , Toni Choueiri , Nizar Tannir , Alexandre Lebeaut , Ronald Chen , Olumide Gbolahan , American Society Of Clinical Oncology , Clinical Oncology , Executive Vice President , Chief Scientific Officer , Ghassan Abou Alfa ,

Ipsen : announces CELESTIAL phase 3 pivotal trial results in the New England Journal of Medicine -Today at 09:52 am

- Trial results formed the basis of regulatory filings in the U.S. and European Union for CABOMETYX® for previously treated advanced hepatocellular carcinoma -

Paris , 04 July. ....

United States , United Kingdom , France General , Memorial Sloan Kettering Cancer Center , New York , City Of , Brigitte Le Guennec , Eugenia Litz , Ian Weatherhead , Myriam Koutchinsky , Lorenza Rimassa , Ipsen Euronext , Alexandre Lebeaut , Research Development , International Agency For Research On Cancer , European Union , Financial Community , Global External Communications , Humanitas Cancer Center Research Hospital , European Commission , Corporate External Communications , Drug Administration , New England Journal , Clinical Oncology , Gastrointestinal Cancers Symposium , Deputy Director ,

Treatment Combo Shows 'Clinical Benefit' in Liver Cancer Trial

The combination of a tyrosine kinase inhibitor with an immune checkpoint inhibitor significantly improved progression-free survival in patients with hepatocellular carcinoma, shows a new study. ....

United States , San Francisco , Lorenza Rimassa , Robin Kate Kelley , University Of California , Humanitas University , Lancet Oncology , Hepatocellular Carcinoma , Liver Cancer , Hepatocellular Cancer , Ancer Liver , Ancer Hepatocellular , Biologic Therapy , Malignant Kidney Neoplasm , Kidney Cancer , Renal Cell Cancer , Renal Cell Carcinoma , Ancer Kidney , Ancer Renal Cell , Tyrosine Kinase Inhibitor , Gastrointestinal Hemorrhage , Gastrointestinal Bleeding ,

A Role for Neoadjuvant Immunotherapy in Liver Cancer?

Two small trials demonstrate safety, activity of checkpoint inhibitors in perioperative setting ....

New York , United States , Thomasu Marron , Ahmed Omar Kaseb , Neoadjuvant Cemiplimab , Mike Bassett , Nicola Personeni , Lorenza Rimassa , Humanitas University , Icahn School Of Medicine At Mount Sinai , Md Anderson Cancer Center , Cancer Center , Icahn School , Mount Sinai , New York City , Lancet Gastroenterology , Nivolumab Alone , Liver Cancer , Hepatocellular Carcinoma ,